30177679 | SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. | Nat Commun | 2018 Sep 3 | Huang LY | doi: 10.1038/s41467-018-06038-y. |
18386774 | Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. | Hum Mutat | 2008 May | Medina PP | doi: 10.1002/humu.20730. |
28232072 | BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. | J Mol Cell Cardiol | 2017 Apr | Willis MS | doi: 10.1016/j.yjmcc.2017.02.003 |
22362300 | BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro. | J Cancer Res Clin Oncol | 2012 Jun | Bai J | doi: 10.1007/s00432-012-1172-8 |
12566296 | Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. | Cancer Res | 2003 Feb 1 | Reisman DN | - |
17075831 | Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. | Prostate | 2007 Feb 1 | Sun A | - |
25504753 | Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo. | Mol Cancer Ther | 2015 Feb | Kwon SJ | doi: 10.1158/1535-7163.MCT-14-0372 |
15887247 | BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. | J Cell Physiol | 2005 Nov | Rosson GB | - |
21317927 | MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. | Oncogene | 2011 Jun 30 | Schramedei K | doi: 10.1038/onc.2011.15 |
21730156 | Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. | Proc Natl Acad Sci U S A | 2011 Dec 20 | Okamoto N | doi: 10.1073/pnas.1015171108 |
11719516 | Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. | J Biol Chem | 2002 Feb 15 | Strobeck MW | - |
11950834 | SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. | J Biol Chem | 2002 Jun 21 | Lee D | - |
27145366 | BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer. | Oncotarget | 2016 Jun 14 | Zhu X | doi: 10.18632/oncotarget.9038. |
27486753 | Mechanism of BRG1 silencing in primary cancers. | Oncotarget | 2016 Aug 30 | Marquez-Vilendrer SB | doi: 10.18632/oncotarget.10593. |
29750276 | Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling. | Endocrinology | 2018 Jun 1 | Gillis NE | doi: 10.1210/en.2018-00128. |
25115300 | BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. | Cancer Res | 2014 Nov 15 | Orvis T | doi: 10.1158/0008-5472.CAN-14-0061 |
28899659 | BRG1 promotes VEGF-A expression and angiogenesis in human colorectal cancer cells. | Exp Cell Res | 2017 Nov 15 | Lan J | doi: 10.1016/j.yexcr.2017.09.013 |
12684665 | Mutation analysis of the BRG1 gene in prostate cancer clinical samples. | Int J Oncol | 2003 May | Valdman A | - |
19448667 | The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. | Oncogene | 2009 Jul 9 | Naidu SR | doi: 10.1038/onc.2009.121 |
25684411 | The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells. | Oral Dis | 2015 Jul | Wang HC | doi: 10.1111/odi.12323 |
20137775 | Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. | Am J Hum Genet | 2010 Feb 12 | Schneppenheim R | doi: 10.1016/j.ajhg.2010.01.013 |
25808524 | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | J Cell Physiol | 2015 Nov | Wu Q | doi: 10.1002/jcp.24991. |
24993775 | Long non-coding RNA urothelial carcinoma associated1 induces cell replication by inhibiting BRG1 in 5637 cells. | Oncol Rep | 2014 Sep | Wang X | doi: 10.3892/or.2014.3309 |
28038711 | SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. | Ann Diagn Pathol | 2017 Feb | Herpel E | doi: 10.1016/j.anndiagpath.2016.10.006 |
24362264 | MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. | Cancer Discov | 2014 Mar | Romero OA | doi: 10.1158/2159-8290.CD-13-0799 |
23533649 | BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. | PLoS One | 2013 | Bai J | doi: 10.1371/journal.pone.0059772 |
27630343 | Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast. | Anticancer Res | 2016 Sep | Do SI | - |
21092585 | [Expression of BRG1 and BRM proteins in prostatic cancer]. | Zhonghua Bing Li Xue Za Zhi | 2010 Sep | Liu XB | - |
23872584 | A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. | Cancer Res | 2013 Sep 1 | Oike T | doi: 10.1158/0008-5472.CAN-12-4593 |
15240517 | Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. | Clin Cancer Res | 2004 Jul 1 | Fukuoka J | - |
22407764 | The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. | EMBO Mol Med | 2012 Jul | Romero OA | doi: 10.1002/emmm.201200236 |
27373334 | BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells. | Mol Cell | 2016 Jul 21 | Wang H | doi: 10.1016/j.molcel.2016.05.038 |
27029062 | Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells. | Oncotarget | 2016 May 10 | Wu Q | doi: 10.18632/oncotarget.8384. |
27852072 | The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. | Oncotarget | 2016 Dec 27 | Lin S | doi: 10.18632/oncotarget.13326. |
27223259 | The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation. | Oncotarget | 2016 Jun 21 | Wu Q | doi: 10.18632/oncotarget.9505. |
29423809 | Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT). | Methods Mol Biol | 2018 | Lang JD | doi: 10.1007/978-1-4939-7471-9_20. |
30286321 | In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF. | Comput Biol Chem | 2018 Dec | S AS | doi: 10.1016/j.compbiolchem.2018.07.001 |
29288038 | BRG1 is correlated with poor prognosis in colorectal cancer. | Hum Pathol | 2018 Mar | Pyo JS | doi: 10.1016/j.humpath.2017.12.013 |
29535420 | LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. | Oncogene | 2018 Jun | Chen Z | doi: 10.1038/s41388-018-0203-6 |